{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:propranolol",
  "owner": "cardio",
  "kind": "drug",
  "slug": "propranolol",
  "name": "Propranolol",
  "aliases": [],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Propranolol is a beta-blocker. The US label read, for propranolol hydrochloride tablets (taken by mouth), lists several heart and vessel uses, of which this page records four: hypertension; decreasing angina frequency and increasing exercise tolerance in patients with angina pectoris; controlling the ventricular rate in atrial fibrillation with a rapid ventricular response; and reducing cardiovascular mortality in stable patients who have survived the acute phase of a myocardial infarction. The label also lists another heart use and uses outside the heart, which this page does not record.",
  "summary_technical": "RxNorm ingredient 8787; UNII F8A3652H1V. The label names the substance as propranolol hydrochloride, so UNII F8A3652H1V is the UNII of the hydrochloride salt and is a broad match. MeSH descriptor D011433 is Propranolol. Class: beta-Adrenergic Blocker (FDA established pharmacologic class, RxClass). The label read is the Amneal Pharmaceuticals NY LLC label for propranolol hydrochloride tablets, applications ANDA071972 and ANDA071976, effective 2026-06-10 in openFDA. The tablet label of a generic sponsor was read because it is a plain immediate-release tablet label; the Inderal LA, InnoPran XL and Hemangeol labels (other products of the same substance) were not read. This page records label indications and the class only: no trial result and no dose is given. The label also lists migraine prophylaxis, essential tremor, hypertrophic subaortic stenosis and pheochromocytoma; those uses were not recorded.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": "2026-11-08",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "8787",
      "normalized_value": "8787",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "F8A3652H1V",
      "normalized_value": "F8A3652H1V",
      "match": "broad",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D011433",
      "normalized_value": "D011433",
      "match": "exact",
      "version": "read 2026-11-08",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart"
      ],
      "condition-area": [
        "hypertension",
        "coronary-and-vascular-disease",
        "arrhythmias"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": null
  },
  "content_digest": "977dc904e56a1c9095fd9e83a708cab1f569c8640f4f6d61167bc7bec2eb9d15",
  "review": {
    "content_digest": "977dc904e56a1c9095fd9e83a708cab1f569c8640f4f6d61167bc7bec2eb9d15",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-propranolol-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:propranolol",
      "category": "descriptive",
      "statement": "The US label of Propranolol hydrochloride tablets, in the Amneal Pharmaceuticals NY LLC version dated 2026-06-10 in openFDA, lists the medicine for the management of hypertension; to decrease angina frequency and increase exercise tolerance in patients with angina pectoris; to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response; and to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of myocardial infarction.",
      "context": {
        "id": "cardio:ctx-fda-propranolol-label-us",
        "label": "People for whom the US label of propranolol hydrochloride tablets lists one of the four heart or vessel indications recorded here: hypertension, angina pectoris, atrial fibrillation with a rapid ventricular response, survivors of the acute phase of myocardial infarction",
        "recipient": "unknown",
        "population": "Patients described in the heart and vessel passages of the indications section of the label. The label does not state an age range in the passages read.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Not stated in the label passages read",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Patients with hypertension",
            "Patients with angina pectoris",
            "Patients with atrial fibrillation and a rapid ventricular response",
            "Clinically stable patients who have survived the acute phase of myocardial infarction"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label also lists migraine prophylaxis, essential tremor, hypertrophic subaortic stenosis and pheochromocytoma; those uses were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-08",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], INDICATIONS AND USAGE",
          "applicability_note": "The label sentences that give the indications named in the statement, each quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-propranolol-amneal-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:25Z",
            "content_hash": "58aa79ab4fa6d5f88acbbfcb992c5236ebf3aee11476e255e1eefae3929e0d7d",
            "source_effective_date": "2026-06-10",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-propranolol-amneal",
            "source_type": "regulator",
            "title": "openFDA drug label record for Propranolol hydrochloride tablets, Amneal Pharmaceuticals NY LLC label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2214d0c95d-418f-40a8-bad3-e20c82424960%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 14d0c95d-418f-40a8-bad3-e20c82424960 (manufacturer Amneal Pharmaceuticals NY LLC, application ANDA071972 and ANDA071976), returned on 2026-11-08. The label text is dated 2026-06-10 (effective_time). Other openFDA records of propranolol labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-08, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wa21-openfda-label-propranolol.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20260610.",
          "snapshot": {
            "id": "cardio:openfda-label-propranolol-amneal-2026-11-08",
            "retrieved_at": "2026-11-08T20:38:25Z",
            "content_hash": "58aa79ab4fa6d5f88acbbfcb992c5236ebf3aee11476e255e1eefae3929e0d7d",
            "source_effective_date": "2026-06-10",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-propranolol-amneal",
            "source_type": "regulator",
            "title": "openFDA drug label record for Propranolol hydrochloride tablets, Amneal Pharmaceuticals NY LLC label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2214d0c95d-418f-40a8-bad3-e20c82424960%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 14d0c95d-418f-40a8-bad3-e20c82424960 (manufacturer Amneal Pharmaceuticals NY LLC, application ANDA071972 and ANDA071976), returned on 2026-11-08. The label text is dated 2026-06-10 (effective_time). Other openFDA records of propranolol labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-08, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wa21-openfda-label-propranolol.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "0dc692122e32cab55903df9fd0a9f6d7d2d89fdad1baa53994295709a04dd2b0",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-propranolol-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Propranolol is a beta-adrenergic blocker (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:beta-blockers",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-8787-2026-11-08",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists management of hypertension as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-propranolol-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists control of ventricular rate in atrial fibrillation with a rapid ventricular response as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:atrial-fibrillation",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-propranolol-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists reducing cardiovascular mortality after the acute phase of myocardial infarction as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:myocardial-infarction",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-propranolol-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05419193",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05419193-2025-07-14",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda016418",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda016418-2011-03-17",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda016419",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda016419-2008-04-01",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda018031",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda018031-2011-03-17",
          "locator": "products[0].active_ingredients[1].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda018553",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda018553-2023-11-07",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda019059",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda019059-2001-11-01",
          "locator": "products[0].active_ingredients[1].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda019536",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda019536-1990-02-14",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda021438",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda021438-2023-12-22",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda205410",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda205410-2026-08-28",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/propranolol/",
  "context_path": "api/v1/context/cardio--propranolol.md"
}
